NDRA - ENDRA Life Sciences Inc Stock Price, Fair Value and News

$3.68+0.33 (+9.85%)

Delayed

Max Portfolio Pct.

Check

Valuation

Check

Stock Quality:

Max Portfolio Pct.

Check

Valuation

Check

NDRA Price Action

Last 7 days

-6.8%

Last 30 days

-8.2%

Last 90 days

-38.8%

Trailing 12 Months

-99.1%

NDRA RSI Chart

NDRA Valuation

Market Cap

2.1M

Price/Earnings (Trailing)

-0.18

Price/Sales (Trailing)

404.31

EV/EBITDA

0.1

Price/Free Cashflow

-0.28

NDRA Price/Sales (Trailing)

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

NDRA Fundamentals

NDRA Revenue

Revenue (TTM)

6.2K

NDRA Earnings

Earnings (TTM)

-11.5M

Earnings Growth (Yr)

-184.27%

Earnings Growth (Qtr)

-76.25%

NDRA Profitability

Operating Margin

100.00%

EBT Margin

-186393.70%

Return on Equity

-449.46%

Return on Assets

-258.47%

Free Cashflow Yield

-358.47%

NDRA Investor Care

Shares Dilution (1Y)

8914.41%

Diluted EPS (TTM)

-56.94

Revenue & Growth

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs

Net sales

Year	Q1	Q2	Q3	Q4
2018	265.3K	178.9K	92.5K	6.2K
2017	0	460.9K	406.3K	351.6K
2016	0	0	0	515.6K

Get all data in R, Python etc through our Historical Stock Data APIs

About ENDRA Life Sciences Inc

ENDRA Life Sciences Inc. develops technology for improving the capabilities of clinical diagnostic ultrasound. The company develops thermo-acoustic enhanced ultrasound technology that transmits sound waves, which bounce off tissues, organs, and blood in the body for use in the treatment of nonalcoholic fatty liver disease, as well as in tissue composition, temperature monitoring, vascular imaging, and tissue perfusion. It also offers diagnostic imaging technologies, such as computed tomography, magnetic resonance imaging, and ultrasound that allow physicians to look inside a person's body to guide treatment or gather information about medical conditions, such as broken bones, cancers, signs of heart disease, or internal bleeding. The company has a collaborative research agreement with General Electric Company. ENDRA Life Sciences Inc. was incorporated in 2007 and is based in Ann Arbor, Michigan.

CEO	Mr. Francois Michelon
WEBSITE	endrainc.com
SECTOR	Healthcare
INDUSTRY	Diagnostics & Research
EMPLOYEES	21

ENDRA Life Sciences Inc Frequently Asked Questions

What is the ticker symbol for ENDRA Life Sciences Inc? What does NDRA stand for in stocks?

NDRA is the stock ticker symbol of ENDRA Life Sciences Inc. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of ENDRA Life Sciences Inc (NDRA)?

As of Thu Apr 17 2025, market cap of ENDRA Life Sciences Inc is 2.07 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of NDRA stock?

You can check NDRA's fair value in chart for subscribers.

Is ENDRA Life Sciences Inc a good stock to buy?

The fair value guage provides a quick view whether NDRA is over valued or under valued. Whether ENDRA Life Sciences Inc is cheap or expensive depends on the assumptions which impact ENDRA Life Sciences Inc's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for NDRA.

What is ENDRA Life Sciences Inc's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Thu Apr 17 2025, NDRA's PE ratio (Price to Earnings) is -0.18 and Price to Sales (PS) ratio is 404.31. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. NDRA PE ratio will change depending on the future growth rate expectations of investors.